GUTS
Price
$1.52
Change
+$0.02 (+1.33%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
73.46M
35 days until earnings call
SCPH
Price
$4.08
Change
+$0.11 (+2.78%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
209.06M
28 days until earnings call
Interact to see
Advertisement

GUTS vs SCPH

Header iconGUTS vs SCPH Comparison
Open Charts GUTS vs SCPHBanner chart's image
Fractyl Health
Price$1.52
Change+$0.02 (+1.33%)
Volume$5.84K
Capitalization73.46M
scPharmaceuticals
Price$4.08
Change+$0.11 (+2.78%)
Volume$2.72K
Capitalization209.06M
GUTS vs SCPH Comparison Chart in %
Loading...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GUTS vs. SCPH commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a Buy and SCPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (GUTS: $1.50 vs. SCPH: $3.96)
Brand notoriety: GUTS and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 55% vs. SCPH: 54%
Market capitalization -- GUTS: $73.46M vs. SCPH: $209.06M
GUTS [@Biotechnology] is valued at $73.46M. SCPH’s [@Biotechnology] market capitalization is $209.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, SCPH is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 3 TA indicator(s) are bullish while SCPH’s TA Score has 4 bullish TA indicator(s).

  • GUTS’s TA Score: 3 bullish, 7 bearish.
  • SCPH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than GUTS.

Price Growth

GUTS (@Biotechnology) experienced а -5.06% price change this week, while SCPH (@Biotechnology) price change was +1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.91%. For the same industry, the average monthly price growth was +17.27%, and the average quarterly price growth was +18.94%.

Reported Earning Dates

GUTS is expected to report earnings on Aug 13, 2025.

SCPH is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+12.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCPH($209M) has a higher market cap than GUTS($73.5M). SCPH YTD gains are higher at: 11.864 vs. GUTS (-27.184). SCPH has higher annual earnings (EBITDA): -83.9M vs. GUTS (-95.83M). SCPH has more cash in the bank: 57.5M vs. GUTS (42.1M). SCPH has less debt than GUTS: SCPH (52.4M) vs GUTS (61.4M). SCPH has higher revenues than GUTS: SCPH (42M) vs GUTS (60K).
GUTSSCPHGUTS / SCPH
Capitalization73.5M209M35%
EBITDA-95.83M-83.9M114%
Gain YTD-27.18411.864-229%
P/E RatioN/AN/A-
Revenue60K42M0%
Total Cash42.1M57.5M73%
Total Debt61.4M52.4M117%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GUTSSCPH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HXGBY10.070.07
+0.72%
Hexagon AB
IBJHF2.06N/A
N/A
Ibstock PLC
NBVAF0.06N/A
N/A
Nubeva Technologies Ltd.
CMGGF1.47N/A
N/A
Commercial International Bank Ltd.
CANQF0.01-0.01
-37.82%
CanaQuest Medical Corporation

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with SCPH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then SCPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-2.60%
SCPH - GUTS
34%
Loosely correlated
+2.59%
ADPT - GUTS
34%
Loosely correlated
N/A
IPSC - GUTS
34%
Loosely correlated
+2.25%
RCKT - GUTS
33%
Loosely correlated
+5.34%
GLUE - GUTS
33%
Poorly correlated
+1.81%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with CRSP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
+2.59%
CRSP - SCPH
46%
Loosely correlated
+7.09%
BEAM - SCPH
45%
Loosely correlated
+5.84%
AURA - SCPH
44%
Loosely correlated
+1.46%
YMAB - SCPH
44%
Loosely correlated
-0.24%
AVIR - SCPH
43%
Loosely correlated
+0.41%
More